Vir Biotechnology EVP Vanina de Verneuil reports sale of $41,939.262 in common shares
VIR•Vir Biotechnology executive Vanina de Verneuil sold 3,750 shares on Nov. 2 and 3, 2026, for a reported total of $41,939.262. Her direct beneficial ownership stood at 110,193 shares afterward.
1. Share sale
Vanina de Verneuil, Vir Biotechnology’s executive vice president, general counsel and corporate secretary, sold 1,343 shares at $11.334 each on Nov. 2, 2026, and 2,407 shares at $11.10 each on Nov. 3. Her direct beneficial ownership stood at 110,193 shares after the transactions.
